Practice-Changing Data From EASL 2018

April 11-15, 2018; Paris, France
Listen to downloadable audio from a live Webinar in which Stefan Zeuzem, MD, assessed the clinical impact of new data reported at the Paris meeting and answered case questions from participants.
Stefan Zeuzem, MD
Format: Audio (.mp3)
File Size: 8.36 MB
Released: April 26, 2018

Listen to downloadable audio from a live Webinar in which Stefan Zeuzem, MD, assessed the clinical impact of new data reported at the Paris meeting and answered case questions from participants. (~45 minutes)

Stefan Zeuzem, MD, has disclosed that he has received consulting fees from AbbVie, Gilead Sciences, Intercept, Janssen, and Merck and fees for non-CME/CE services from AbbVie, Gilead Sciences, and Merck.

Acknowledgements

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Educational grant provided by:
AbbVie
Gilead Sciences

Related Content

Low-level viremia in hep B (HBV): Robert S. Brown, Jr., MD, MPH, on possible causes and when to switch to entecavir, tenofovir, or combination therapy

Robert S. Brown, Jr., MD, MPH Released: September 24, 2018

Susanna Naggie, MD, MHS, on HCV and HIV coinfection FAQs and challenges. Guideline-based strategies, common DAA and ART drug interactions (DDIs).

Susanna Naggie, MD, MHS Released: September 13, 2018

Deciding between TAF, TDF, and entecavir: Jordan J. Feld, MD, MPH, outlines clinical scenarios where he recommends a specific first-line HBV therapy.

Jordan J. Feld, MD, MPH Released: August 17, 2018

Tool, education to avoid drug interactions, follow guidelines when choosing anti-HCV DAA and anti-HIV ART drugs for patients with HCV/HIV coinfection.

Susanna Naggie, MD, MHS Mark S. Sulkowski, MD Released: August 6, 2018

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?